- Clinical applications of functional imaging in oncology
- Fusion imaging: positron emission tomography, computed tomography, magnetic resonance imaging
- Novel radiopharmaceuticals targeting tumors
- Metabolic response assessment to therapy
18 F-Fluorodeoxyglucose positron-emission tomography for the investigation of malignancy in patients with suspected paraneoplastic neurologic syndromes and negative or indeterminate conventional imaging: a retrospective analysis of the Ontario PET...
Curr Oncol. 2019 Aug;26(4):e458-e465
FDG-PET parameters predict for recurrence in anal cancer - results from a prospective, multicentre clinical trial.
Radiat Oncol. 2019 Aug 06;14(1):140
Radiother Oncol. 2019 Mar 19;135:107-114
Utility of 18F-FDG-PET/CT imaging in patients with recurrent gynecological malignancies prior to pelvic exenteration.
Int J Gynecol Cancer. 2019 Mar 28;:
The contribution of multiparametric pelvic & whole body MR to interpretation of 18F-fluoromethylcholine or 68Ga-HBED-CC PSMA-11 PET/CT in patients with biochemical failure following radical prostatectomy.
J Nucl Med. 2019 Mar 22;:
Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell Tumors.
JCO Clin Cancer Inform. 2018 Dec;(2):1-12
Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer: A Randomized Clinical Trial.
JAMA Netw Open. 2018 Sep 07;1(5):e182081
Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter Registry.
Radiology. 2018 Dec 04;:181519
A Prospective, Multi-site, International Comparison of F-18 fluoro-methyl-choline, multi-parametric magnetic resonance and Ga-68 HBED-CC (PSMA-11) in men with High-Risk Features and Biochemical Failure after Radical Prostatectomy: Clinical Performance...
J Nucl Med. 2018 Nov 15;:
Quantitative assessment of dynamic 18F-Fluoromethycholine PET and Dynamic Contrast Enhanced MRI in High Risk Prostate Cancer.
Br J Radiol. 2018 Nov 01;:20180568
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Affiliate Scientist, Techna Institute for the Advancement of Technology for Health (Techna)
Associate Professor, Department of Medical Imaging, University of Toronto